Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?

Dermatologic Surgery

Volumn 23, Issue 8, 1997, Pages 625-630

  Spencer, James M ^a,b   Tannenbaum, Alan ^a   Sloan, Luke ^a   Amonette, Rex A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RECURRENCE; CLINICAL ARTICLE; CURETTAGE; ELECTROSURGERY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

EID: 0030824919     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1997.tb00379.x     Document Type: Article

References (37)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
2. Fears TR, Scotto J. Changes in skin cancer morbidity between 1971-72 and 1977-78. J Natl Cancer Inst 1982;69:365-70.
3. Gallagher RP, Ma B, McLean DI, et al. Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973-1987. J Am Acad Dermatol 1990;23:413-21.
4. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. J Am Med Assoc 1989;262:2097-100.
5. Rowe DE, Carroll RJ, Day CD. Long term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
6. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodessication. J Dermatol Surg Oncol 1991;17:720-6.
7. Edens BL, Bartlow GA, Haghighi P, et al. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma. J Am Acad Dermatol 1983;9:383-8.
8. Suhge d'Aubermont PC, Bennett RG. Failure of curettage and electrodessication for removal of basal cell carcinoma. Arch Dermatol 1984;120:1456-60.
9. Salasche SJ. Curettage and electrodessication in the treatment of midfacial basal cell epithelioma. J Am Acad Dermatol 1983;8:496-503.
10. Miller SJ. Biology of basal cell carcinoma (part 1). J Am Acad Dermatol 1991;24:1-13.
11. Salasche SJ. Status of curettage and desiccation in the treatment of primary basal cell carcinoma. J Am Acad Dermatol 1984;10:285-7.
12. Wagner RF, Cottel WI. Multifocal recurrent basal cell carcinoma following tumor treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987;17:1047-9.
13. DePanfilis G, Colli V, Manfrede G, et al. In situ identification of mononuclear cells infiltrating cutaneous carcinoma: an immunohistochemical study. Acta Dermatovener 1979;59:219.
14. Kohchiyama A, Oka D, Ueki H. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma. J Am Acad Dermatol 1987;113:833-8.
15. Ceballos PI, Barnhill RL. Spontaneous regression of cutaneous tumors. Advances in Dermatol 1993;8:229-60.
16. Miller SJ. Biology of basal cell carcinoma (part II). J Am Acad Dermatol 1991;24:161-75.
17. Dellon AL, Elfenbein GJ, Orlando JC. Impairment of thymus-derived lymphoid cell function in patients with basal cell carcinoma. J Surg Oncol 1984;25:92-7.
18. Myskowski PL, Safai B, Good RA. Decreased lymphocyte blastogenic responses in patients with basal cell carcinoma. J Am Acad Dermatol 1981;4:711-4.
19. Weimar VM, Ceilley RI, Gocken JA. Cell-mediated immunity in patients with basal and squamous cell skin cancer. J Am Acad Dermatol 1980;2:143-7.
20. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122:1288-93.
21. Hoxtell EO, Mandel JS, Murray SS, et al. Incidence of skin carcinoma after renal transplantation. Arch Dermatol 1977;113:436-8.
22. Parnes R, Safai B, Myskowski PL. Basal cell carcinomas and lymphoma: biologic behavior and associated factors in sixty three patients. J Am Acad Dermatol 1988;19:1017-23.
23. Weinstein GD, Frost P. Cell proliferation in human basal cell carcinoma. Cancer Res 1970;30:724-8.
24. Shanoff L, Spira M, Hardy S. Basal cell carcinoma: a statistical approach to rational management. Plast Reconstr Surg 1967;39: 619-24.
25. Curson C, Weedon D. Spontaneous regression in basal cell carcinomas. J Cutan Pathol 1979;6:432-7.
26. Hunt MJ, Halliday GM, Weedon D, et al. Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 1994; 130:1-8.
27. Mozzanica N, Cattaneo A, Boneschi V, et al. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2 interferon. Arch Dermatol Res 1990;282:311-7.
28. Gerstein W. Transplantation of basal cell epithelioma to the rabbit. Arch Dermatol 1963;88:834.
29. Lyles TW, Freeman RG, Knox JM. Transplantation of basal cell epitheliomas. J Invest Dermatol 1960;34:205-35.
30. Pawowiski A, Haberman HF. Heterotransplantation of human basal cell carcinomas in nude mice. J Invest Dermatol 1979;72:310.
31. Klein E,m Holtermann O, Milgrom H, et al. Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system. Med Clinic North Am 1976;60:389-418.
32. Levis WR, Kraemer KH, Klingler WG, et al. Topical immunotherapy of basal cell carcinoma with dinitrochlorobenzene. Cancer Res 1973;33:3036-42.
33. Pascal RR, Hobby LW, Lattes R, et al. Prognosis of incompletely excised vs completely excised basal cell carcinoma. Plast Reconstr Surg 1968;41:328-32.
34. Lauritzen RE, Johnson RE, Spratt JS. Pattern of recurrence in basal cell carcinoma. Surgery 1965;57:813-6.
35. Sharnoff LB, Spira M, Hardy SB. Basal cell carcinoma: a statistical approach to rational management. Plast Reconstr Surg 1967;39: 619-24.
36. Bieley HC, Kirsner RS, Reyes BA, et al. The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma. J Am Acad Dermatol 1992; 26:754-6.
37. Waldorf H, Fewkes J. Wound healing. Adv Dermatol 1995;10:77-97.